Shirley Milenca Quintana Truyenque (Shirley Quintana)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 2

Top Topics

Multiple Myeloma

Cerebrospinal Fluid

Physical Activity

Tyrosine Kinase

Top Venues

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Luisa Corrêa de Araujo Koury, Haesook T Kim, Maria Soledad Undurraga, Juan Ramon Navarro-Cabrera, Victor Salinas, Pablo Muxi, Raul A M Melo, Ana Beatriz F Gloria, Katia B B Pagnano, Elenaide C Nunes, Rosane Isabel Bittencourt, Ninoska Rojas, Shirley Milenca Quintana Truyenque, Ana Ilda Ayala-Lugo, Ana Carolina Oliver, Lorena Lobo de Figueiredo-Pontes, Fabiola Traina, Frederico Moreira, Evandro M Fagundes, Bruno Kosa L Duarte, Analí Pamela Mora-Alferez, Percy Ortiz-Guerra, Jose Luis Untama, Martin S Tallman, Raul C Ribeiro, Arnold Ganser, Richard James Dillon, Peter J M Valk, Miguel Angel Sanz, Bob Löwenberg, Nancy Berliner, Eduardo Magalhaes Rego
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia. Blood (2024)
Jule Vasquez, Rossana Ruiz, Karina Aliaga, Fernando Valencia, Marco Villena, Shirley Milenca Quintana Truyenque, Tatiana Vidaurre, Luis Casanova
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up. JCO global oncology 7 (2021)